SEER Inquiry System - View
| Print Question |
| Question: 20120077 |
|---|
|
Status Final References Source 1: 2012 Heme & Lymph Manual & DB pgs: Notes: Source 2: SEER Site/Type Table pgs: Notes: Question Primary site/Histology--Heme & Lymphoid Neoplasms: Please advise regarding a situation with inconsistency between the EDITS based on the SEER Site/Type Table and the Heme/Lymph Rules and DB. See discussion. Discussion According to the Heme/Lymph Rules and DB - CLL/SLL (chronic lymphocytic leukemia/small lymphocytic lymphoma) is to be coded 9823/3 – regardless of site of origin. The code 9670/3 which used to be used for SLL has been made “Obsolete”. The DB and rules instruct the registrar to use the code 9823/3 for these cases whether presenting in lymph nodes or bone marrow. Unfortunately, the SEER Site/Type Table only lists C420, C421 or C424 as allowable codes for Primary Site when histology = 9823/3. And an EDIT is triggered when entering a lymph node or other site with histology code 9823/3. The registrar cannot “fix” the “error” without ignoring the new rules or coding the site to C420, C421, or C424. Yes, the edit can be overridden and will be in the interim...but, this is frustrating and confusing to registrars when they are following the rules but still getting an EDIT that they cannot correct without ignoring the new rules.
Do we know when the Site/Type Tables will be updated to bring them up-to-date with new rules and coding guidelines and the Heme/Lymph DB and soon-to-be Solid Tumor MP/H DB?
Continue to override the edit for now. We are coordinating with NAACCR to update relevant SEER and NAACCR edits.
|